Hillman Group Capital Trust Announces Cash Distributions on Trust Preferred Securities
CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) — The Hillman Companies, Inc. (“Hillman” or the “Company”), – Doug Cahill, President and […]
QuestCap to Host Corporate Update Webinar on Investments in Glenco Medical, Amino Therapeutics and Spectral Analytics
Investor Webinar to be held Monday, August 10th at 10 am Eastern TimeNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES […]
Ebix Reports $28.8M of Operating Cash Flow Despite COVID-19
JOHNS CREEK, Ga., Aug. 07, 2020 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), today announced the following results for the […]
Iovance Biotherapeutics to Present at BTIG Biotechnology Conference 2020
SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel […]
Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Paltusotine received Orphan Drug Designation for the treatment of acromegalyHalf of the enrolled patients in the ongoing Phase 2 ACROBAT […]
AnPac Bio Validating Approved COVID-19 Antibody Test
SAN JOSE, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review
Priority Review accelerates FDA review time, with a Prescription Drug User Fee Act (PDUFA) target action on March 7, 2021If […]
Arbutus Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Phase 1a/1b clinical trial for AB-729, a subcutaneously delivered RNAi agent, remains on track with results from additional cohorts expected […]
Orgenesis Second Quarter 2020 Revenue Increases 55% Reflecting Progress of POCare Platform
Provides update on COVID-19 therapeutic programsReports cash and cash equivalents of $97.5 million as of June 30, 2020GERMANTOWN, Md., Aug. […]
Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance
CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third […]
